The reporting OR for Mtb infection with PD-1/PD-L1 inhibitors was 1.79 (95% CI 1.42 to 2.26) (p<0.0001),61 demonstrating increased risk of active TB. This evidence concerns the gene PDCD1 and tuberculosis.